Indonesia approves Merck's COVID-19 pill for emergency use

Indonesia has approved Merck & Co Inc's COVID-19 antiviral pill molnupiravir for emergency use, the country's food and drug agency said in a statement.

Published : 14 Jan 2022, 06:22 AM
Updated : 14 Jan 2022, 06:22 AM

A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by US-based Merck and Ridgeback Biotherapeutics.

Toufique Imrose Khalidi
Editor-in-Chief and Publisher